CAS 1644539-04-7

Eptinezumab

CAS : 1644539-04-7

Degré de pureté : 95%

Ref: IN-DA00ATC4

Eptinezumab

CAS : 1644539-04-7

Eptinezumab is a humanised monoclonal antibody targeting CGRP (calcitonin gene-related peptide), which prevents CGRP binding to its receptor, migraine.

Degré de pureté : 96.9% (SDS-PAGE); 99.8% (SEC-HPLC) - 96.9% (SDS-PAGE); 99.8% (SEC-HPLC)

Couleur et forme : Transparent Liquid

Masse moléculaire : 143.27 kDa (Predicted)

Ref: TM-T76678